NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0370
-0.0100 (-21.28%)
At close: Dec 17, 2025
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $4.6 million as of December 18, 2025. Its market cap has decreased by -55.48% in one year.
Market Cap
4.60M
Enterprise Value
57.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 4.60M, a decrease of -98.64%. That is a compound annual growth rate of -83.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 4.60M | -80.50% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 789.81M |
| Elite Pharmaceuticals | 537.07M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 396.23M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 291.10M |